Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered

To attain effective and safe pharmacotherapy, formulations in (pre)term neonates should enable extensive dose flexibility. During product development and subsequent authorization and clinical use of such formulations, there is also a need for informed decisions on excipient exposure: in addition to...

Descripción completa

Detalles Bibliográficos
Autores principales: Valeur, Kristine Svinning, Holst, Helle, Allegaert, Karel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105181/
https://www.ncbi.nlm.nih.gov/pubmed/30174435
http://dx.doi.org/10.1007/s40290-018-0243-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105181/
https://www.ncbi.nlm.nih.gov/pubmed/30174435
http://dx.doi.org/10.1007/s40290-018-0243-9

Ejemplares similares